Published Research

Lustgarten-Funded Published Papers

Publishing researchers is a critical part of the research process. This process includes the following steps:

  • Scientists produce data in the laboratory to prove their idea
  • Scientists summarize their findings in a manuscript and send it to a scientific journal
  • The manuscript is judged by the reviewers, who are other scientists working in the same field/topic
  • Reviewers can ask for further clarifications about the research (e.g. more experiments, more details, etc.)
  • Once the reviewers approve, the manuscript is published in the journal and available for the scientific community

Publishing research is critically important as it fosters cooperation and is the only way to find solutions to the incredibly complex challenges associated with pancreatic cancer. It also starts a   dialogue with fellow researchers. Since our inception, Lustgarten-funded researchers have published thousands of papers in leading scientific journals.

Matthew Vander Heiden, M.D., Ph.D.

Lustgarten Research Investigator
Koch Institute at MIT
“Altered exocrine function can drive adipose wasting in early pancreatic cancer”
Nature
June 20, 2018
https://www.nature.com/articles/s41586-018-0235-7

Matthew Vander Heiden, M.D., Ph.D.

Lustgarten Research Investigator
Koch Institute at MIT
and

Brian Wolpin, M.D., M.P.H.

Lustgarten Translational Clinical Investigator
Dana-Farber Cancer Center
“Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer”
JAMA
June 19, 2018
https://jamanetwork.com/journals/jama/article-abstract/2685154

Brian Wolpin, M.D., M.P.H

Lustgarten Translational Clinical Investigator
Dana-Farber Cancer Center
“Real-time genomic characterization of advanced pancreatic cancer to enable precision medicine”
Cancer Discovery
June 14, 2018
http://cancerdiscovery.aacrjournals.org/content/early/2018/06/14/2159-8290.CD-18-0275

David Tuveson, M.D., Ph.D.

Lustgarten Chief Scientist
Director, Lustgarten Foundation Laboratory, Cold Spring Harbor Laboratory
“Organoid profiling identifies common responders to chemotherapy in pancreatic cancer”
Cancer Discovery
May 31, 2018.
http://cancerdiscovery.aacrjournals.org/content/early/2018/05/30/2159-8290.CD-18-0349

Douglas Fearon, M.D.

Lustgarten Distinguished Scholar
Cold Spring Harbor Laboratory, Weill Cornell Medical Center
“Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases”
Science
May 17, 2018
http://science.sciencemag.org/content/early/2018/05/16/science.aao4908

Bert Vogelstein, M.D.

Lustgarten Distinguished Scholar
Johns Hopkins Kimmel Cancer Center
“Liquid biopsy promises early detection for cancer”
Science
January 18, 2018
http://www.sciencemag.org/news/2018/01/liquid-biopsy-promises-early-detection-cancer

David Tuveson, M.D., Ph.D.

Lustgarten Chief Scientist
Director, Lustgarten Foundation Laboratory, Cold Spring Harbor Laboratory
and

Michael E. Feigin, Ph.D.

Cold Spring Harbor Laboratory
“Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinoma”
Nature Genetics
May 8, 2017
http://www.nature.com/articles/ng.3861

Douglas Fearon, M.D.

Lustgarten Distinguished Scholar
Cold Spring Harbor Laboratory and Weill Cornell Medical Center
“Tumor-induced IL-6 reprograms host metabolism to suppress anti-tumor immunity”
Cell Metabolism
November 7, 2016
http://www.cell.com/cell-metabolism/home

 

 

Patient and Caregiver Resources

We have lots of informative resources designed to help you get the information you need quickly and easily.

Patient and Caregiver Resources